Skip to main content
logo
Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
14.30
0.00 (0.00%)
Sep 9, 2026, 11:26 AM EST

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Crop Science Revenue
21.72B21.62B22.26B
Pharmaceuticals Revenue
17.52B17.83B18.13B
Consumer Health Revenue
5.81B5.80B5.87B
All Other Segment Revenue
-302.00M327.00M
Enabling Functions and Consolidation Revenue
-20.00M19.00M
Revenue (Other)
323.00M--
Revenue (Total)
45.38B45.58B46.61B

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Europe/Middle East/Africa Revenue
12.94B13.50B13.98B
North America Revenue
17.20B16.73B16.48B
Asia/Pacific Revenue
7.33B7.52B8.07B
Latin America Revenue
7.90B7.83B8.08B
Revenue (Total)
45.38B45.58B46.61B

Adjusted EBITDA

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Crop Science Adjusted EBITDA
4.85B4.19B4.33B
Pharmaceuticals Adjusted EBITDA
4.39B4.53B4.72B
Consumer Health Adjusted EBITDA
1.32B1.34B1.37B
All Other Segment Adjusted EBITDA
-277.00M62.00M
Enabling Functions and Consolidation Adjusted EBITDA
--662.00M-352.00M
Operating Income (Total)
941.00M-1.08B-71.00M